Article Details

AstraZeneca, MSD get Japenese nod for breast cancer drug Lynparza - Medical Dialogues

Retrieved on: 2022-08-28 18:13:38

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca, MSD get Japenese nod for breast cancer drug Lynparza - Medical Dialogues. View article details on HISWAI: https://medicaldialogues.in/news/industry/pharma/astrazeneca-msd-get-japenese-nod-for-breast-cancer-drug-lynparza-98159

Excerpt

New Delhi: AstraZeneca and MSD's Lynparza (olaparib) has been approved in Japan for the adjuvant treatment of patients with BRCA-mutated (BRCAm), ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up